MRI与CT灌注对胶质母细胞瘤切除边界的确定及根治性的预测。

IF 2.7 3区 医学 Q2 CLINICAL NEUROLOGY
Frontiers in Neurology Pub Date : 2025-05-14 eCollection Date: 2025-01-01 DOI:10.3389/fneur.2025.1572845
Rustam Talybov, Tatiana Trofimova, Vadim Mochalov, Sergey Karasev, Vladislava Gorshkova, Tatiana Kleschevnikova, Irina Karasyova, Artem Batalov, Natalia Zakharova, Elena Gaijsina, Igor Pronin
{"title":"MRI与CT灌注对胶质母细胞瘤切除边界的确定及根治性的预测。","authors":"Rustam Talybov, Tatiana Trofimova, Vadim Mochalov, Sergey Karasev, Vladislava Gorshkova, Tatiana Kleschevnikova, Irina Karasyova, Artem Batalov, Natalia Zakharova, Elena Gaijsina, Igor Pronin","doi":"10.3389/fneur.2025.1572845","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preoperative identification of diffuse glioma boundaries remains an unsolved problem of modern neurooncology. The main problem is the heterogeneity of the tumor being manifested by simultaneous presence of both contrast-enhancing and non-contrasting but hyperperfused regions on imaging. Perfusion technologies are known to be a reliable tool in identifying areas with intact BBB and increased proliferative activity of vascular endothelium.</p><p><strong>Aim: </strong>The purpose of this study is to evaluate the impact of MRI and CT perfusion data in preoperative planning of surgical resection in order to achieve the maximum volume of cytoreduction and to prolong relapse-free period.</p><p><strong>Methods: </strong>The study included 74 patients with the morphologically and immunohistochemically verified diagnosis of \"glioblastoma NOS.\" The patients were divided into 2 groups depending on the perfusion data and the extent of tumor resection. Group 1 of patients had a surgery with the preoperative use of perfusion techniques and the resection of the contrast-enhancing and hyperperfused portion of the tumor (<i>n</i> = 42), group 2 of patients had a surgery with preoperative use of perfusion techniques and resection of only the contrast-enhancing component of the tumor (<i>n</i> = 32).</p><p><strong>Results: </strong>The results of the study show that the surgery directed to the resection of contrast-positive and hyperperfused tumor portions has an advantage when compared with surgery aimed at removing only the contrast-enhancing part of the tumor. In group 1, the median relapse-free period was 15 months, while the relapse-free survival in 6 and 12 months was 92 and 55% which exceeded the results in the second group, in which the median was 9 months, and the relapse-free survival in 6 and 12 months was 66 and 9% (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Our study shows that the use of perfusion techniques in preoperative planning of the resection volume has a favorable potential and high diagnostic value. Perfusion tools may be contribute to the most objective assessment of all tumor components. The prolongation of the relapse-free period was achieved by taking into account the factor as the resection of both the contrast-enhanced component and the contrast-negative component with high vascular permeability detected by perfusion techniques.</p>","PeriodicalId":12575,"journal":{"name":"Frontiers in Neurology","volume":"16 ","pages":"1572845"},"PeriodicalIF":2.7000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116550/pdf/","citationCount":"0","resultStr":"{\"title\":\"The determination of the boundaries and prediction the radicality of glioblastoma resection using MRI and CT perfusion.\",\"authors\":\"Rustam Talybov, Tatiana Trofimova, Vadim Mochalov, Sergey Karasev, Vladislava Gorshkova, Tatiana Kleschevnikova, Irina Karasyova, Artem Batalov, Natalia Zakharova, Elena Gaijsina, Igor Pronin\",\"doi\":\"10.3389/fneur.2025.1572845\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Preoperative identification of diffuse glioma boundaries remains an unsolved problem of modern neurooncology. The main problem is the heterogeneity of the tumor being manifested by simultaneous presence of both contrast-enhancing and non-contrasting but hyperperfused regions on imaging. Perfusion technologies are known to be a reliable tool in identifying areas with intact BBB and increased proliferative activity of vascular endothelium.</p><p><strong>Aim: </strong>The purpose of this study is to evaluate the impact of MRI and CT perfusion data in preoperative planning of surgical resection in order to achieve the maximum volume of cytoreduction and to prolong relapse-free period.</p><p><strong>Methods: </strong>The study included 74 patients with the morphologically and immunohistochemically verified diagnosis of \\\"glioblastoma NOS.\\\" The patients were divided into 2 groups depending on the perfusion data and the extent of tumor resection. Group 1 of patients had a surgery with the preoperative use of perfusion techniques and the resection of the contrast-enhancing and hyperperfused portion of the tumor (<i>n</i> = 42), group 2 of patients had a surgery with preoperative use of perfusion techniques and resection of only the contrast-enhancing component of the tumor (<i>n</i> = 32).</p><p><strong>Results: </strong>The results of the study show that the surgery directed to the resection of contrast-positive and hyperperfused tumor portions has an advantage when compared with surgery aimed at removing only the contrast-enhancing part of the tumor. In group 1, the median relapse-free period was 15 months, while the relapse-free survival in 6 and 12 months was 92 and 55% which exceeded the results in the second group, in which the median was 9 months, and the relapse-free survival in 6 and 12 months was 66 and 9% (<i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Our study shows that the use of perfusion techniques in preoperative planning of the resection volume has a favorable potential and high diagnostic value. Perfusion tools may be contribute to the most objective assessment of all tumor components. The prolongation of the relapse-free period was achieved by taking into account the factor as the resection of both the contrast-enhanced component and the contrast-negative component with high vascular permeability detected by perfusion techniques.</p>\",\"PeriodicalId\":12575,\"journal\":{\"name\":\"Frontiers in Neurology\",\"volume\":\"16 \",\"pages\":\"1572845\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116550/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fneur.2025.1572845\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fneur.2025.1572845","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:弥漫性胶质瘤的术前边界识别是现代神经肿瘤学尚未解决的问题。主要的问题是肿瘤的异质性,在成像上同时存在对比增强和非对比但高灌注的区域。灌注技术被认为是一种可靠的工具,可以识别血脑屏障完整和血管内皮增殖活性增加的区域。目的:本研究的目的是评估MRI和CT灌注数据对手术切除术前规划的影响,以达到最大体积的细胞减少,延长无复发期。方法:74例经形态学和免疫组织化学检查诊断为“胶质母细胞瘤NOS”的患者。根据灌注情况及肿瘤切除程度将患者分为两组。第1组患者术前采用灌注技术切除对比增强部分和肿瘤高灌注部分(n = 42),第2组患者术前采用灌注技术切除肿瘤对比增强部分(n = 32)。结果:本研究结果表明,切除对比阳性和高灌注肿瘤部分的手术与仅切除对比增强部分的手术相比具有优势。第一组患者的中位无复发期为15 个月,6、12 个月的无复发生存期分别为92、55%,超过第二组患者的中位9 个月,6、12 个月的无复发生存期分别为66、9% (p )结论:我们的研究显示灌注技术在术前规划切除体积方面具有良好的潜力和较高的诊断价值。灌注工具可能有助于最客观地评估所有肿瘤成分。无复发期的延长是通过考虑灌注技术检测到的对比度增强成分和对比度阴性成分的切除来实现的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The determination of the boundaries and prediction the radicality of glioblastoma resection using MRI and CT perfusion.

Background: Preoperative identification of diffuse glioma boundaries remains an unsolved problem of modern neurooncology. The main problem is the heterogeneity of the tumor being manifested by simultaneous presence of both contrast-enhancing and non-contrasting but hyperperfused regions on imaging. Perfusion technologies are known to be a reliable tool in identifying areas with intact BBB and increased proliferative activity of vascular endothelium.

Aim: The purpose of this study is to evaluate the impact of MRI and CT perfusion data in preoperative planning of surgical resection in order to achieve the maximum volume of cytoreduction and to prolong relapse-free period.

Methods: The study included 74 patients with the morphologically and immunohistochemically verified diagnosis of "glioblastoma NOS." The patients were divided into 2 groups depending on the perfusion data and the extent of tumor resection. Group 1 of patients had a surgery with the preoperative use of perfusion techniques and the resection of the contrast-enhancing and hyperperfused portion of the tumor (n = 42), group 2 of patients had a surgery with preoperative use of perfusion techniques and resection of only the contrast-enhancing component of the tumor (n = 32).

Results: The results of the study show that the surgery directed to the resection of contrast-positive and hyperperfused tumor portions has an advantage when compared with surgery aimed at removing only the contrast-enhancing part of the tumor. In group 1, the median relapse-free period was 15 months, while the relapse-free survival in 6 and 12 months was 92 and 55% which exceeded the results in the second group, in which the median was 9 months, and the relapse-free survival in 6 and 12 months was 66 and 9% (p < 0.001).

Conclusion: Our study shows that the use of perfusion techniques in preoperative planning of the resection volume has a favorable potential and high diagnostic value. Perfusion tools may be contribute to the most objective assessment of all tumor components. The prolongation of the relapse-free period was achieved by taking into account the factor as the resection of both the contrast-enhanced component and the contrast-negative component with high vascular permeability detected by perfusion techniques.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Neurology
Frontiers in Neurology CLINICAL NEUROLOGYNEUROSCIENCES -NEUROSCIENCES
CiteScore
4.90
自引率
8.80%
发文量
2792
审稿时长
14 weeks
期刊介绍: The section Stroke aims to quickly and accurately publish important experimental, translational and clinical studies, and reviews that contribute to the knowledge of stroke, its causes, manifestations, diagnosis, and management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信